RD

Rajiv Dhawan

Active Director Director DIN 05247611
DIN 05247611 First appointment Feb 2007 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2007
Shareholding value •••• Premium profile

About Rajiv Dhawan

Data last updated:

Rajiv Dhawan is a Director at Rubodex Herbal Private Limited (since 2007). The company operates in FMCG. Rubodex Herbal Private Limited reported revenue of ₹1.83 Cr (FY 2025).

DIN 05247611
Primary Designation Director
Industry FMCG
First Appointment 12 Feb 2007
Oldest Company Age 32 yrs
Largest company Rubodex Herbal Private Limited · ₹1.83 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rubodex Herbal Private Limited U74899DL1993PTC055940
Director12 Feb 20071993₹1.83 Cr (FY 2025)Active

Board colleagues of Rajiv Dhawan

NameDINCompanyDesignation
Charu Dhawan01996736Rubodex Herbal Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rubodex Herbal Private Limited
Premium access

Shareholding and investment profile for Rajiv Dhawan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Dhawan

Rajiv Dhawan currently holds 1 directorship: Rubodex Herbal Private Limited (Director, since 12 Feb 2007, revenue ₹1.83 Cr (FY 2025)).

Rajiv Dhawan was first appointed on 12 Feb 2007 as Director at Rubodex Herbal Private Limited.

The current boards of Rajiv Dhawan's companies include Charu Dhawan (Rubodex Herbal Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available